Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 124,517	$ 86,140
General and administrative	17,741	18,821
Total operating expenses	142,258	104,961
Loss from operations	(142,258)	(104,961)
Other income (expense):
Interest income	12,682	8,325
Other income (expense):	102	(19)
Total other income	12,784	8,306
Net loss	$ (129,474)	$ (96,655)
Net loss per share, basic (in dollars per share)	$ (2.2)	$ (2.14)
Net loss per share, diluted (in dollars per share)	$ (2.2)	$ (2.14)
Weighted average shares used to compute net loss per share, basic (in shares)	58,743,522	45,247,098
Weighted average shares used to compute net loss per share, diluted (in shares)	58,743,522	45,247,098